Imperial partners with laboratory in DR Congo for Rapid Polio detection
Late detection of poliovirus transmission is one of the greatest risks to polio eradication. Imperial developed a method for rapid detection of polio.
Real-time epidemic forecasting tool to support global outbreak monitoring
Imperial researchers have developed a new forecasting tool to support global outbreak monitoring for COVID-19 and other deadly diseases.
Brazil-UK team played vital role in COVID-19 response
A team of Brazilian and UK scientists played a key role in identifying some of the most devastating COVID-19 variants, such as P.1.
Meningitis jab could be cost-effective for combating gonorrhoea
A meningitis vaccine could be cost-effective in combating gonorrhoea amid rising cases globally and increased resistance to drug treatments.
People with Omicron variant less likely hospitalised compared to Delta variant
People with the Omicron variant of SARS-CoV-2 were less likely to be admitted to hospital or to die, compared to those with the Delta variant.
Report estimates economic and social benefits of booster roll-out in Indonesia
Rolling out a booster vaccination campaign would benefit Indonesia by US$381 billion in the next year according to the latest Imperial report.
Video
Laboratories move to White City: new opportunities and incredible views
As four epidemiology teams settle into their new spaces, we check in with the researchers to find out what they are up to on the White City campus.
Some reduction in hospitalisation for Omicron v Delta in England: early analysis
Estimates suggest Omicron cases are 15% less likely to attend hospital, and 40% less likely to be hospitalised for a night or more, compared to Delta.
Celebrating two years Jameel Institute: key milestones from the last 12 months
As we mark the second anniversary of the Jameel Institute, the team has published their annual report highlighting some key achievements.
Omicron largely evades immunity from past infection or two vaccine doses
The Omicron variant largely evades immunity from past infection or two vaccine doses according to the latest Imperial modelling.
